当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2013年第5期
编号:13170318
市售不同厂家人参多糖注射液的质量评价(3)
http://www.100md.com 2013年3月1日 《中国中药杂志》 2013年第5期
     [10]中国药典.一部[S].2010.

    [11]张维杰.糖复合物生化研究技术[M].杭州:浙江大学出版社, 1999.

    [12]李计萍.中药多糖有效部位研究中相对分子质量及分布研究相关问题探讨[J].药物分析杂志, 2009, 29(10):1768.

    [13]范慧红.2010年版《中国药典》中多糖类药物标准的修订[J]. 中国药学杂志, 2010, 45(17):1294.

    [14]张剑波, 田庚元.糖类的高效毛细管电泳[J].有机化学, 1998(18):88.

    [15]丁侃, 方积年.多糖类药物的毛细管电泳分析方法及其应用[J].色谱, 1999, 17(4):346.

    Quality evaluation of polysaccharide of

    ginseng injections from different manufacturers

    WAN Qin1,2, XIAO Wei1,2, WANG Zhen-zhong1,2 , LIU Li-li1,2

    (1.Jiangsu Kanion Pharmaceutical Co., Ltd, Lianyungang 222001, China;

    2.State Key Laboratory of Pharmaceutical Process New-tech for Chinese Medicine, Lianyungang 222001, China)

    [Abstract]Objective: To evaluate injections of ginseng polysaccharide from 4 different manufacturers of 5 batches on the market.Method: Based on quality analysis, normal examinations were investigated, and monosaccharide composition and the molecular weight of polysaccharide in ginseng injections were performed.Result: Products from 4 different manufacturers were in line with the requirements of quality standard and Chinese Pharmacopeia (2010 edition).But there were great differences in molecular weight and monosaccharide composition.Conclusion: It is suggested to enhance the quality standard to ensure the medication safety use.

    [Key words]polysaccharide of ginseng injection; quality evaluation; relative molecular weight; monosaccharide composition

    doi:10.4268/cjcmm20130513

    [责任编辑曹阳阳], http://www.100md.com(万琴 萧伟 王振中 刘莉莉)
上一页1 2 3